CONSENT FOR PUBLICATION
CONFLICT OF INTEREST
The author declares no conflict of interest, financial or otherwise.
The author wants to acknowledge the Institute of Pharmaceutical Research, GLA University, Mathura, India for providing necessary facilities for the compilation of this work.
Luigi, M.; Gianfranco, N. New robotic technologies in cancer colon screening. Clin. Cancer Drugs, 2018, 5, 68-74.
Lévy, E.; Piedbois, P.; Buyse, M. Meta-analysis group In C. Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors. J. Clin. Oncol., 1998, 16, 3537-3541.
Chourasia, M.K.; Jain, S.K. Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharmaceut Sci., 2003, 6, 33-66.
Anitha, A; Sreeranganathan, M; Chennazhi, KP; Lakshmanan, V.K Jayakumar, R Corrigendum to "In vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies" [Eur. J. Pharmaceut. Biopharmaceut., 2014, 88, 238-251]. 2019, 139, 44-46.
Wang, J.; Peng, C-A. Anticancer effectiveness of polymeric drug nanocarriers on colorectal cancer cells. Annual Conference, 2011, pp. 3249-3252.
Ansari, M.; Sadarani, B.; Majumdar, A. Colon targeted beads loaded with pterostilbene: formulation, optimization, characterization and in vivo evaluation. Saudi Pharmaceut J., 2019, 27, 71-81.